Early Trial Of New Multi-kinase Inhibitor Shows Impressive Activity In Thyroid Cancer
Monday, October 27, 2008 - 09:35
in Health & Medicine
Preliminary trials of a new multi-kinase inhibitor have indicated it has impressive tumor shrinkage activity in patients with a difficult to treat type of thyroid cancer. The results have put the drug's development on a fast track, prompting the accelerated initiation of a large phase III trial.
Read the whole article on Science Daily
More from Science Daily
Related
- Early trial of new multi-kinase inhibitor shows impressive activity in thyroid cancerThu, 23 Oct 2008, 13:15:17 EDT
- Novel enzyme inhibitor paves way for new cancer drugFri, 16 May 2008, 10:42:42 EDT
- EGFR protects cancer cells from starvation via a kinase-independent mechanismMon, 5 May 2008, 14:08:10 EDT
- Meta-analyses of global trials finds in favor of aromatase inhibitorsThu, 11 Dec 2008, 16:57:26 EST
- Combining targeted therapy drugs may treat previously resistant tumorsSun, 30 Nov 2008, 14:07:42 EST